Overview
Vaginal Cancer Human Serum for Research
Our Vaginal Cancer Serum is sourced from IRB-consented donors clinically diagnosed with vaginal cancer. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for biomarker studies.
Product Features
- Collected from clinically confirmed donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
Donor Metadata
- Oncology diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported allergy and infectious disease history
Applications
- Biomarker discovery for vaginal cancer
- Metabolic and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Vaginal cancer serum is available in standard and custom volumes. For international orders or documentation requirements, please email [email protected] to ensure compatibility with your country’s regulations.
Protocols and Documentation
Document Type | Technical Document |
---|---|
PDF > | Serum Isolation |
Publications
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.